Radio and PodcastLive Radio & PodcastsScience & Medicine
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics is an episode from New FDA Approvals. This science & medicine ep...
About This Episode
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics is an episode from New FDA Approvals. This science & medicine episode is made for li...
Podcast
This episode belongs to New FDA Approvals.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 18, 2018, 10:24 long, audio available.
Related Episodes
Continue listening to more episodes from New FDA Approvals.